FDA Commissioner Scott Gottlieb, MD

FDA Proposes Sweeping Drug Development Changes

In an effort to promote the most promising opportunities and to address complex drug development issues, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, this week introduced several “fundamental advances” regarding how the agency evaluates drugs for safety and effectiveness, as well as the manner in which clinical trials are guided. “These include […]